Polynomial equations have long served as a cornerstone of mathematical analysis, offering a framework to understand functions, curves, and dynamic systems. In recent years, the study of these ...

A total of 23 studies from 11 registries in eight countries spanning Europe, North America, and Oceania were identified and included in the review. Most studies were retrospective in nature and ...

Comparison of Physician-Documented Versus Patient-Reported Collection of Comorbidities Among Patients With Prostate Cancer Upon First Visit to the Urology Clinic Data from claims and electronic ...

Recent advances in healthcare research have increasingly leveraged routinely collected administrative data to monitor cancer recurrence. This approach circumvents the delays and resource-intensive ...

After 5 years, Kisqali® plus endocrine therapy consistently shows significant and clinically meaningful benefit in invasive disease-free survival1 Kisqali remains the only CDK4/6 inhibitor ...

Basel, December 10, 2024 – Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali ® (ribociclib) that underscore the extended efficacy beyond the ...

This is a preview. Log in through your library . Abstract The stability analysis for numerical methods provides insight into their suitability in practice. A stability condition involving the spectral ...

We consider two semiclassical extensions of the Laguerre weight and their associated sets of orthogonal polynomials. These polynomials satisfy a three-term recurrence relation. We show that the ...

‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective, ...

Poster published at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting shows the final 5 year safety data from the Phase IIb breast cancer clinical trial. Final safety conclusions ...

Forty-three percent of trials did not include data on post-recurrence treatment. Researchers identified a lack of data on post-recurrence treatment in trials supporting recent approvals of ...